Daktari Diagnostics is a healthcare solutions company that enables enhanced disease management in both developed and developing countries. Its portable point-of-care diagnostic platform, with built-in wireless connectivity and an intuitive cloud-based data management system, provides the real-time information necessary to improve clinical outcomes for individual patients and support global disease elimination programs. Daktari’s initial products will target viruses of worldwide significance, including Hepatitis C and HIV. The company recently announced a Hepatitis C partnership with Merck & Co (MSD). A Cambridge, Massachusetts, USA-based, venture-funded technology company, Daktari has assembled an outstanding team of investors, scientists, engineers, and experts in health care delivery. The Company is always interested in motivated individuals with a passion for performance.